Profile picture

Mr Diogo Ferreira

Santa Maria Hospital - CHULN, Lisbon (Portugal)
Membership: HFA Member
Follow
Logo ESC

Contributor content

Real-world predictors of adverse outcomes in hcm: who is really at risk?
Presentation
Real-world predictors of adverse outcomes in hcm: who is really at risk?
Read more
99mTC-DPD bone scintigraphy in ATTR-CM: are we missing patients? can you suggest me more titles?
Presentation
99mTC-DPD bone scintigraphy in ATTR-CM: are we missing patients? can you suggest me more titles?
Read more
ICD benefit in hypertrophic cardiomyopathy: a real-world analysis
Presentation
ICD benefit in hypertrophic cardiomyopathy: a real-world analysis
Read more
Performance of cardiotoxicity risk scores in a tertiary center cardio-oncology clinic
Presentation
Performance of cardiotoxicity risk scores in a tertiary center cardio-oncology clinic
Read more
Timing matters: early furosemide administration and mortality in acute heart failure
Presentation
Timing matters: early furosemide administration and mortality in acute heart failure
Read more
Predictors of early left ventricular recovery in takotsubo syndrome: a single-center study
Presentation
Predictors of early left ventricular recovery in takotsubo syndrome: a single-center study
Read more
Safety and outcomes of iFR vs. FFR in coronary revascularization: a real-world cohort study
Presentation
Safety and outcomes of iFR vs. FFR in coronary revascularization: a real-world cohort study
Read more
Hemoglobin, hematocrit and heart failure: the SGLT2 inhibitor connection
Presentation
Hemoglobin, hematocrit and heart failure: the SGLT2 inhibitor connection
Read more
Tafamidis and patient-reported outcomes in ATTR cardiomyopathy
Presentation
Tafamidis and patient-reported outcomes in ATTR cardiomyopathy
Read more
Metabolic predictors of adverse outcomes in heart failure with reduced ejection fraction: insights from a prospective cohort study
Presentation
Metabolic predictors of adverse outcomes in heart failure with reduced ejection fraction: insights from a prospective cohort study
Read more

ESC 365 is supported by

novartis Explore sponsored resources